美好醫療(301363.SZ):目前尚不涉及基礎材料研發工作
格隆匯6月13日丨美好醫療(301363.SZ)在互動平臺表示,公司主要從事醫療器械精密組件及產品的設計開發、製造和銷售,爲全球醫療器械企業提供從產品研發到批量交付的全流程一站式服務,致力於成爲全球卓越的醫療科技服務商。多年來公司在呼吸健康、聽力康復、血糖管理、心血管、體外診斷等多個醫療器械細分領域,與全球多家醫療器械百強企業和創新型高科技醫療企業在產品研發、工藝技術開發、精密製造等方面開展了全方位的深度合作。公司專注於依據客戶產品的特定需求,從液態硅膠、高分子材料等多元材料庫中甄選並匹配最優解決方案,目前尚不涉及基礎材料研發工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.